Naoko Hayata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Naoko Hayata has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Akino Okamoto
Department of Gastroenterology and Hepatology, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Kita-ku, Sakai 591-8025, Osaka, Japan
2 shared publications - Atsushi Hosui
Department of Gastroenterology and Hepatology, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Kita-ku, Sakai 591-8025, Osaka, Japan
2 shared publications - Hiroki Murai
Department of Gastroenterology and Hepatology, Osaka Rosai Hospital, 1179-3 Nagasonecho, Kita Ward, Sakai 591-8025, Osaka, Japan
2 shared publications - Kohsaku Ohnishi
Department of Gastroenterology and Hepatology Osaka Rosai Hospital Sakai Osaka Japan
2 shared publications - Motohiro Hirao
Department of Gastroenterology and Hepatology, Osaka Rosai Hospital, 1179-3 Nagasonecho, Kita Ward, Sakai 591-8025, Osaka, Japan
2 shared publications - Takafumi Tanimoto
Department of Gastroenterology and Hepatology, Osaka Rosai Hospital, 1179-3 Nagasone-cho, Kita-ku, Sakai 591-8025, Osaka, Japan
2 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6769
Association Between CT Attenuation and Mechanical Basket Lithotripsy Failure in Common Bile Duct Stones: A Single-Centre Retrospective Exploratory Study
Background: Mechanical lithotripsy is used for difficult common bile duct (CBD) stones, but failure to fragment a grasped stone can complicate endoscopic management. Evidence regarding the association between preprocedural computed tomography (CT) attenuation and mechanical lithotripsy outcome is limited. This study explored the association between CT attenuation of CBD stones and mechanical basket lithotripsy failure in a single-centre retrospective cohort. Methods: We retrospectively analysed 37 patients in whom a CBD stone was grasped with a basket catheter, could not be extracted directly, and underwent attempted intraductal mechanical crushing between 1 April 2017 and 31 March 2023. Lithotripsy failure was defined as inability to fragment the grasped stone despite use of a dedicated crusher handle. Continuous variables were compared using the Mann–Whitney U test and categorical variables using Fisher’s exact test. CT attenuation analyses were restricted to CT-positive stones with measurable attenuation values (n = 27). Exploratory receiver operating characteristic (ROC) analyses were performed, and areas under the curve (AUCs) were accompanied by nonparametric bootstrap 95% confidence intervals (CIs) based on 10,000 resamples. No clinical CT attenuation threshold was proposed. Results: Mechanical lithotripsy succeeded in 31 patients and failed in 6. CT attenuation was measurable in 27 patients (21 successes and 6 failures). Among these patients, the failure group had higher mean CT attenuation than the success group (median 241 [IQR 217.8–473.5] HU vs. 76 [67–88] HU; p = 0.00064) and higher maximum CT attenuation (386 [269.8–589.3] HU vs. 123 [102–133] HU; p = 0.00133). Exploratory ROC analysis showed an AUC of 0.968 (bootstrap 95% CI, 0.871–1.000) for mean CT attenuation and 0.940 (bootstrap 95% CI, 0.800–1.000) for maximum CT attenuation. These estimates were derived and evaluated in the same small dataset and were therefore considered exploratory. Conclusions: In this small, selected retrospective cohort, higher CT attenuation values were observed among the six patients with mechanical basket lithotripsy failure. These findings are exploratory and require confirmation in larger prospective studies using standardized CT protocols before CT attenuation can be incorporated into procedural decision-making.
- 31 August 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6769
Open AccessAssociation Between CT Attenuation and Mechanical Basket Lithotripsy Failure in Common Bile Duct Stones: A Single-Centre Retrospective Exploratory Study
Background: Mechanical lithotripsy is used for difficult common bile duct (CBD) stones, but failure to fragment a grasped stone can complicate endoscopic management. Evidence regarding the association between preprocedural computed tomography (CT) attenuation and mechanical lithotripsy outcome is limited. This study explored the association between CT attenuation of CBD stones and mechanical basket lithotripsy failure in a single-centre retrospective cohort. Methods: We retrospectively analysed 37 patients in whom a CBD stone was grasped with a basket catheter, could not be extracted directly, and underwent attempted intraductal mechanical crushing between 1 April 2017 and 31 March 2023. Lithotripsy failure was defined as inability to fragment the grasped stone despite use of a dedicated crusher handle. Continuous variables were compared using the Mann–Whitney U test and categorical variables using Fisher’s exact test. CT attenuation analyses were restricted to CT-positive stones with measurable attenuation values (n = 27). Exploratory receiver operating characteristic (ROC) analyses were performed, and areas under the curve (AUCs) were accompanied by nonparametric bootstrap 95% confidence intervals (CIs) based on 10,000 resamples. No clinical CT attenuation threshold was proposed. Results: Mechanical lithotripsy succeeded in 31 patients and failed in 6. CT attenuation was measurable in 27 patients (21 successes and 6 failures). Among these patients, the failure group had higher mean CT attenuation than the success group (median 241 [IQR 217.8–473.5] HU vs. 76 [67–88] HU; p = 0.00064) and higher maximum CT attenuation (386 [269.8–589.3] HU vs. 123 [102–133] HU; p = 0.00133). Exploratory ROC analysis showed an AUC of 0.968 (bootstrap 95% CI, 0.871–1.000) for mean CT attenuation and 0.940 (bootstrap 95% CI, 0.800–1.000) for maximum CT attenuation. These estimates were derived and evaluated in the same small dataset and were therefore considered exploratory. Conclusions: In this small, selected retrospective cohort, higher CT attenuation values were observed among the six patients with mechanical basket lithotripsy failure. These findings are exploratory and require confirmation in larger prospective studies using standardized CT protocols before CT attenuation can be incorporated into procedural decision-making.
- Open Access
Impact of Serum Albumin Levels on Prognosis and Recurrence in Patients with Hepatocellular Carcinoma
Background: Liver function is a critical factor, both in the selection of treatment and in the prediction of prognosis in patients with hepatocellular carcinoma (HCC). The ALBI grade, introduced as a more objective method of assessing liver function, utilizes serum albumin (Alb) and total bilirubin (Bil) levels. Although albumin is widely recognized for its role in maintaining colloid osmotic pressure and regulating plasma volume, recent studies have implicated it in tumor progression, invasion, and metastasis. The purpose of this study is to determine the impact of serum albumin levels on overall survival (OS) and tumor invasion/metastasis in HCC patients with the same liver function (ALBI grade) at the time of diagnosis. Methods: In this study, 285 patients diagnosed with primary HCC at our institution from 2015 to 2019 were classified by ALBI grade and analyzed. Among them, 78 patients with ALBI grade 2 status were selected to evaluate the impact of albumin level. To further isolate the effect of albumin rather than bilirubin, patients in the ALBI grade 2 cohort were divided into two groups based on mean values of Alb (3.5 g/dL) and Bil (1.0 mg/dL). Alb normal group (Group A): Alb ≥ 3.5 g/dL, Bil ≥ 1.0 mg/dL (n = 42). Bil normal group (Group T): Alb < 3.5 g/dL, Bil < 1.0 mg/dL (n = 36). Liver function was almost the same in these two groups based on the ALBI grade. OS, progression-free survival (PFS), types of recurrence, and pathological findings were compared between the two groups. OS was analyzed by the log-rank test, and comparisons between the two groups were performed by the t-test and chi-square test, with p < 0.05 indicating statistical significance. Results: OS was significantly worse in Group T than in Group A before and after propensity score matching based on age, performance status, and HCC stage (p < 0.001 and p = 0.011). Among the 44 patients who received curative treatment (surgery or radiofrequency ablation), OS was also significantly worse in Group T (p < 0.001). An analysis of the recurrence patterns of 44 curatively treated patients revealed that Group T had significantly shorter PFS (p < 0.001), and all recurrence patterns were multiple (p = 0.002). Pathological analysis in 28 surgical patients showed that serosal invasion was present in significantly more patients in Group T (p = 0.003). Conclusions: Low serum albumin levels in patients with HCC indicate both liver dysfunction and increased tumor invasion and metastasis. Nutritional support and albumin supplementation may help reduce intrahepatic metastases and improve prognosis. Further studies are needed to explore the underlying mechanisms and therapeutic potential.
Open AccessImpact of Serum Albumin Levels on Prognosis and Recurrence in Patients with Hepatocellular Carcinoma
Background: Liver function is a critical factor, both in the selection of treatment and in the prediction of prognosis in patients with hepatocellular carcinoma (HCC). The ALBI grade, introduced as a more objective method of assessing liver function, utilizes serum albumin (Alb) and total bilirubin (Bil) levels. Although albumin is widely recognized for its role in maintaining colloid osmotic pressure and regulating plasma volume, recent studies have implicated it in tumor progression, invasion, and metastasis. The purpose of this study is to determine the impact of serum albumin levels on overall survival (OS) and tumor invasion/metastasis in HCC patients with the same liver function (ALBI grade) at the time of diagnosis. Methods: In this study, 285 patients diagnosed with primary HCC at our institution from 2015 to 2019 were classified by ALBI grade and analyzed. Among them, 78 patients with ALBI grade 2 status were selected to evaluate the impact of albumin level. To further isolate the effect of albumin rather than bilirubin, patients in the ALBI grade 2 cohort were divided into two groups based on mean values of Alb (3.5 g/dL) and Bil (1.0 mg/dL). Alb normal group (Group A): Alb ≥ 3.5 g/dL, Bil ≥ 1.0 mg/dL (n = 42). Bil normal group (Group T): Alb < 3.5 g/dL, Bil < 1.0 mg/dL (n = 36). Liver function was almost the same in these two groups based on the ALBI grade. OS, progression-free survival (PFS), types of recurrence, and pathological findings were compared between the two groups. OS was analyzed by the log-rank test, and comparisons between the two groups were performed by the t-test and chi-square test, with p < 0.05 indicating statistical significance. Results: OS was significantly worse in Group T than in Group A before and after propensity score matching based on age, performance status, and HCC stage (p < 0.001 and p = 0.011). Among the 44 patients who received curative treatment (surgery or radiofrequency ablation), OS was also significantly worse in Group T (p < 0.001). An analysis of the recurrence patterns of 44 curatively treated patients revealed that Group T had significantly shorter PFS (p < 0.001), and all recurrence patterns were multiple (p = 0.002). Pathological analysis in 28 surgical patients showed that serosal invasion was present in significantly more patients in Group T (p = 0.003). Conclusions: Low serum albumin levels in patients with HCC indicate both liver dysfunction and increased tumor invasion and metastasis. Nutritional support and albumin supplementation may help reduce intrahepatic metastases and improve prognosis. Further studies are needed to explore the underlying mechanisms and therapeutic potential.